Effects of natriuretic peptide receptor inhibition on remnant kidney function in rats  by Zhang, Ping L. et al.
Kidney International, Vol. 46 (1994), pp. 414—420
Effects of natriuretic peptide receptor inhibition on remnant
kidney function in rats
PING L. ZHANG, HARALD S. MACKENZIE, JULIA L. TROY, and BARRY M. BRENNER
Renal Division, Department of Medicine, Brigham and Women's Hospital and the Harvard Center for the Study of Kidney Diseases,
Harvard Medical Schoo) Boston, Massachusetts, USA
Effects of natriuretic peptide receptor inhibition on remnant kidney
function in rats. To identiiy the contribution of natriuretic peptide (NP)
activity to the adaptative increases in glomerular filtration rate (GFR),
effective renal plasma flow rate (ERPF) and fractional sodium excretion
(FENa) observed in the remnant kidney, we investigated the acute effects
of administering HS-142-1 (HS), a potent NP receptor antagonist, in 5/6th
nephrectomized (NPX) rats. In addition to normal sodium intake, high or
low sodium intakes were used to stimulate or suppress, respectively,
endogenous NP activity in NPX rats. In rats three days after NPX on high
sodium, HS (20 mg/kg bolus i.v.) reduced GFR from 0.55 0.05 to 0.35
0.04 mI/mm; ERPF from 1.83 0.19 to 1.53 0.16 mI/mm; and FENa
from 7.1 1.1 to 1.6 0.4%, without affecting MAP. Similar changes of
lesser magnitude were observed in NPX rats on normal sodium intake. By
contrast, GFR, ERPF, FENa and MAP were unchanged following HS in
NPX rats on low sodium intake, suggesting that the magnitude of
responses to HS is dependent upon the expected levels of activity of NP.
We conclude that in anesthetized rats, natriuretic peptides contribute to
the compensatory increases in GFR, ERPF and FENa observed in the
remnant kidney under normal and salt-replete conditions.
As a compensatory response to reduced renal excretory capac-
ity, rats subjected to 5/6 nephrectomy (NPX) excrete greatly
elevated amounts of sodium and water per remnant nephron. This
is effected by both increased filtered load of sodium, via increased
glomerular filtration rate (GFR) per nephron, and decreased
tubular reabsorption, as reflected in elevated fractional excretion
of sodium (FENa) [1]. Previous studies from this laboratory
suggest that atrial natriuretic peptide (ANP), released from the
heart in response to plasma volume expansion, may mediate these
adaptive renal responses, at least in part [2, 3]. ANP levels in NPX
rats are elevated in proportion to the chronic dietary sodium
intake [2, 41 and ANP infused into normal rats may promote
natriuresis by decreasing tubule sodium reabsorption and, at
higher doses, by increasing GFR and hence filtered sodium load
[51. Dietary sodium restriction in NPX rats has been demon-
strated to reduce plasma ANP levels and to reduce fractional
sodium excretion concomitantly [2]. Furthermore, administration
of specific anti-ANP antiserum decreased FENa in NPX rats on
high sodium diet [3]. The availability of a novel specific pharma-
cologic antagonist of natriuretic peptide receptors, HS-142-1
(HS), provides a more precise means of defining the role of
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endogenous natriuretic peptides in the functional adaptive re-
sponses of remnant kidneys. The purpose of this study was to
establish the role of natriuretic peptides in mediating the adaptive
hemodynamic and excretory responses in the remnant kidney by
evaluating the acute renal responses to HS at different levels of
chronic salt intake. In protocol A we first sought to confirm the
reported effects [6] of HS administration on the diuretic and
natriuretic responses to acute volume expansion in euvolemic
anesthetized Munich-Wistar rats. In protocol B, we then assessed
the effects of HS administration on the hemodynamic and excre-
tory function of the remnant kidney under conditions of high,
normal or low salt diet, at early and at later stages after partial
renal ablation.
Methods
Adult male MUnich-Wistar rats weighing from 220 to 270 g
were used in the studies. Normal rats in protocol A received
standard rat chow (Rodent Lab Chow 5001; Ralston Purina Co.,
St. Louis, Missouri, USA) and water ad libitum. In protocol B, 12
groups of rats underwent ablation of 5/6 of their total renal mass
by surgical excision of the right kidney and infarction of approx-
imately 2/3 of the left kidney by selective ligation of renal artery
branches. Clearance experiments were carried out in rats either 3
or 14 days after partial nephrectomy (NPX) on high, normal or
low sodium intakes. In the 3 day groups, NPX rats received high
sodium (sodium deficient diet, ICN Biomedicals, Inc., Cleveland,
Ohio, USA) with 1% NaCI water; normal (sodium deficient diet
with 0.4% NaC1 water) or low sodium (sodium deficient diet with
tap water; Fig. 1A). In the 14 day groups, normal sodium intake
was provided by standard rat chow with tap water whereas high
and low sodium intakes were given as in the 3 day groups. Urine
flow and sodium excretion rates were determined from 24-hour
urine collections from individual rats in each group one to two
days before the clearance experiments.
All rats were anesthetized with mactin (0.1 g/kg, i.p.). Body
temperature was maintained between 36 and 37°C by a thermo-
statically controlled heating table. After tracheostomy, the left
femoral artery was cannulated for measurement of mean arterial
blood pressure and intermittent blood sampling at the mid-point
of each clearance period. The right femoral vein was cannulated
for infusion of iso-oncotic rat plasma, volume equivalent to 0.8%
of body weight, over 25 minutes to replace plasma loss due to
anesthesia and surgery [7]. Subsequently, a sustained infusion of
plasma at a rate of 0.6 mI/hr was given. In protocol A, a solution of
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Fig. 1. A. Assignment of groups of rats 3 or 14 days after 5/6 nephrectomy
(NPX) on various levels of daily sodium intakes. B. Daily sodium excretion
from rats 3 or 14 days after 5/6 nephrectomy (NPX) at each level of
sodium intake. Symbols are: (D) high sodium; () normal sodium; ()
low sodium. P < 0.05 vs. low sodium; tP < 0.05 vs. normal sodium.
8% inulin and 1% PAH in isotonic saline was infused continu-
ously at a rate of 20 sl/min throughout each experiment. The left
ureter was cannulated for collection of urine; the bladder (proto-
col A only) was cannulated to allow free drainage of urine from
the right side. In protocol B, NPX rats on high and normal sodium
intakes received continuous infusions of isotonic saline containing
4% inulin and 0.3% PAH at a rate of 20 j.d/min (3.07 j.Eq Na
mm), whereas NPX rats on low sodium intake were infused with
the same solution at 14.2 sl (2.18 sEq Na mm) throughout the
experiments. After a one hour stabilization period, two 15-minute
baseline urine collections were made in all groups prior to the
experimental interventions described below.
Protocol A
After two 15-minute baseline collections of urine, each rat
received either an intravenous bolus dose of vehicle (0.15 ml
isotonic saline) or HS (20 mg/kg) in 0.15 ml isotonic saline. Ten
minutes later, acute volume expansion with isotonic saline (2% of
body weight over 30 mm) was commenced intravenously, during
which two 15-minute urine samples were collected.
Protocol B
In all groups studied in protocol B, two baseline urine collec-
tions were followed by an intravenous bolus of vehicle or HS (20
mg/kg) in 0.15 ml isotonic saline. Ten minutes later, two 15 minute
urine samples were collected.
Analysis
The concentrations of inulin and PAHwere determined using
the anthrone method [8] and a colorimetric technique [9], respec-
tively. Urine volume was determined gravimetrically and GFR
and effective renal plasma flow rate (ERPF) were assessed as
clearances of inulin and PAH, respectively, calculated from
standard formulae. The concentrations of sodium in both plasma
and urine were measured by flame photometry.
Statistical analysis
All data are expressed as mean SEM. Differences between the
baseline and experimental observations within groups were com-
pared by Student's paired t-test. Comparisons between vehicle or
HS treated groups were made using ANOVA followed by Sheffe's
test where appropriate [10]. Significance was accepted at P < 0.05.
Results
Protocol A
Body weights in both groups were similar. Mean arterial blood
pressure (MAP) was not significantly different between groups
either before or after treatment (Fig. 2A). From similar baseline
values for urine flow rate (V), acute volume expansion resulted in
a threefold increase in V and a fourfold increase in sodium
excretion rate (UNaV) in vehicle-treated rats (Fig. 2 B, C). In rats
receiving HS however, a less than 1.5-fold increase in V was
observed. Remarkably, the increase in UNaV was almost com-
pletely abolished during acute saline loading in HS treated rats;
similarly, whereas FENa in the vehicle group increased by more
than threefold, FENa did not change significantly in the HS group
(Table 1), indicating that the decrease in tubule sodium reabsorp-
tion induced by saline loading was abolished by the NP receptor
antagonist. Likewise, the modest increase in GFR during volume
expansion was suppressed in HS-treated rats (Table 1). The
increase in ERPF during saline loading, however, was not com-
pletely suppressed in the HS group nor did HS prevent the modest
reductions in hematocrit or filtration fraction (FF) seen during
saline loading (Table 1).
Protocol B
Daily sodium excretion in NPX rats. Three days after NPX, daily
UNaV (5.3 1.0 mEq/day) in the high salt rats was significantly
higher than in the normal and low sodium rats (1.2 0.1 and 0.3
0.1 mEq/day, respectively; Fig. 1B). Similarly, daily UNaV
reflected the dietary intake of sodium in rats 14 days after NPX on
high (5.9 1.8 mEq/day), normal (1.3 0.2) and low (0.1 0.02)
sodium diet.
Acute clearance studies. Studies were carried out at both 3 and
14 days post-NPX to evaluate the renal responses to acute HS
administration early in the adaptation to renal mass reduction,
A Groups High sodium:
Sodium deficient diet with 1% NaCI
3 Days I Normal sodium:
Sodium deficient diet with 0.4% NaCIafter NPX
[ Low sodium:
Sodium deficient diet with tap water
Protocol B
High sodium:
Sodium deficient diet with 1% NaCI
—
14 Days [Normal sodium:
after NPX
L
0.48% sodium diet with tap water
Low sodium:
Sodium deficient diet with tap water
B Daily sodium excretion
3Days
after NPX
l4Days i*t
after NPX
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Fig. 2. A. Mean blood pressure (MAP), (B) urine flow rate (I'), and (C)
urinaiy sodium excretion rate (UNl") before and during acute volume
expansion in vehicle ('A") or HS treated (—4'-) normal rats. Values
represent mean SE. *P C 0.05 vs. baseline and tP < 0.05 vs. vehicle
treated normal rats in each group.
when functional responses might be expected to predominate, and
later, when structural hypertrophy is also likely to contribute to
the overall adaptive response.
Three days post-NPX
There were no significant differences in body weight among
high (262 8 g, N = 15), normal (262 8 g, N 12), and low
(253 8 g, N = 13) sodium rats. During both baseline and HS
treatment periods, MAP was not significantly different between
vehicle and HS-treated rats at each level of sodium intake (Table
2). Only high sodium rats showed a significant elevation in MAP
after HS, whereas MAP in the other groups remained unchanged.
Baseline values for GFR and ERPF were similar in all groups. HS
administration was associated with sustained, significant reduc-
tions in GFR in high (36%) and normal (14%) sodium rats. In low
sodium rats, on the other hand, GFR was not significantly
changed following HS. ERPF was significantly reduced in high
—
sodium rats following HS, but was not significantly changed in
either normal or low sodium rats. Both V and UNaV were reduced
by 70 to 80% in high sodium rats and by 50 to 65% in normal
sodium rats. In marked contrast, however, neither V nor UuaV
was altered significantly following HS in rats on low salt intake.
Fractional excretion of sodium (FENa) observed during baseline
periods in high sodium rats was twofold higher than in normal
sodium rats and sevenfold higher than in low sodium rats. After
HS treatment, however, FENa in high and normal sodium rats fell
markedly, indicating that the observed decrease in UNaV was due
to increased tubule reabsorption as well as decreased filtered
sodium load. In contrast, in rats on the low sodium diet, FENa was
less dramatically altered. Hematocrit (Hct) was decreased a small
but significant amount after HS only in high sodium rats; in
normal and low sodium rats Uct was unchanged. Under high,
normal and low dietary sodium intake levels, the above indices of
renal excretory and hemodynamic function were all unchanged
—
following vehicle administration in time control groups (Table 2).
Changes in GFR, UNaV and FENa after HS are demonstrated in
Figure 3 at each sodium intake level.
* Fourteen days post -NPX
There were no significant differences in body weight among
high (252 9 g, N = 14), normal (269 5 g, N = 14), and low
(259 11 g, N = 12) sodium rats. During both baseline and IrIS
treatment periods, MAP was not significantly different between
vehicle and HS treated rats at the various level of sodium intake
(Table 3). MAP was significantly elevated in high and normal
sodium rats after HS whereas MAP was unaltered in low sodium
rats after HS. Similar baseline levels of GFR and ERPF were
observed among all groups. HS administration was associated
with significant reductions in GFR of 56, 22 and 14% in high,
normal and low sodium rats, respectively. After HS, ERPF was
also significantly reduced by 51% in high sodium rats, but was
unchanged in the low and normal sodium rats. Filtration fraction
(FF) was significantly reduced after HS, in high sodium rats from
0.29 0.01 to 0.26 0.03 and in normal sodium rats, from 0.28
0.01 to 0.21 0.02, whereas FF was not significantly changed
(0.23 0.01 to 0.21 0.02) in low sodium rats. As in the 24 hour
studies, basal levels of UNaV under anesthesia also reflected levels
of dietary sodium intake. After HS treatment, V was reduced by
approximately 84% and 60% in high and normal sodium rats,
respectively (Table 3). Similarly striking decreases in UNaV were
observed in high (92%) and normal (8 1%) sodium rats, In low
sodium rats, whereas V was not significantly changed following
HS, a small but significant reduction in UNaV was observed. As
A
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Table 1. Glomerular filtration rate (GFR), effective renal plasma flow rate (ERPF), filtration fraction, fractional excretion of sodium (FENa), and
hematocrit (Hct) before and during volume expansion in vehicle and HS treated groups of protocol A
GFR ERPF Filtration
fraction
FENa Hct
mI/mm %
Vehicle group Baseline 1.10 0.09 5.49 0.58 0.21 0.02 1.05 0.26 45.3 0.6
N = 6 VE 1.21 QØ9 6.79 0.59a 0.18 0.02a 3.48 0.59a 42.2 0.7
HS group
N = 7
Baseline
VE
1.12 0.03
1.06 0.08
5.23 0.42
6.19 Q45 0.21 0.020.18 0.01 0.91 0.261.18 044b 46.5 0.942.6 1.2
Abbreviations are: Baseline, average of collection periods 1 and 2; VE, average of volume expansion periods (periods 3 and 4); HS, 20 mg/kg, i.v.
bolus.
P < 0.05 vs. baseline in each group
b P < 0.05 vs. vehicle group
Table 2. Mean arterial pressure (MAP), glomerular filtration rate (GFR), effective renal plasma flow rate (ERPF), urine flow rate (V), sodium
excretion rate (UNaV), fractional excretion of sodium (FENa) and hematocrit (Hct) in response to vehicle or HS in euvolemic rats 3 days after the
5/6 nephrectomy on high, normal (Nor) and low sodium intakes
MAP mm
Hg GFR ml/min ERPF mi/mm V pJ/min UNaV p.Eq/min FEN % Het %
N Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
HighVa 7 125 130 0.57 0.60 2.07 2.23 28.3 28.0 4.0 3.9 5.7 5.5 47
1
47
High-HS" 8 136 142C 0.55 035cd 1.83 1.53c 31.1 94cd 09cd 7.0
1.1
l.5c1 46 44C
Nor-V 6 121 129 0.49 0.47 2.05 2.01 16.4 16.1 2.1 2.0 2.6 2.8 46
1
45
Nor-HS 6 116 131 0.43 0.37c 2.12 2.07 16.4 82Cd
1.7
2.0 0.7c1 3.0 1.3 47 46
Low-V 6 116 122 0.55 0.53 1.96 1.86 14.8 13.9
1.9
0.55 0.51 0.72 0.69 50
1
Low-HS 7 113 121 0.51 0.56 2.17 2.32 13.6 10.4 0.53 0.27 1.18 0.63 47 46
Values are means SE.
a V. vehicle
b HS, 20 mg/kg
P < 0.05 vs. pre value within each group
d P < 0.05 vs. vehicle group
with UNaV, baseline values for 1Na reflected levels of dietary salt
intake. After HS treatment, FENa was significantly decreased by
approximately 83% and 78% in high and normal sodium rats,
respectively. In low sodium rats, 70% decreases in 1Na were also
observed. HS administration was associated with significant reduc-
tions in hematocrit in high and normal sodium rats but not in low
sodium rats. Following vehicle administration, FF was unchanged in
high (0.25 0.02 vs. 0.26 0.02), normal (0.30 0.02 vs. 0.31
0.02) and low (0.24 0.02 vs. 0.22 0.03) sodium rats. None of the
other indices of renal excretory and hemodynamic function was
altered significantly in the time-control rats on high, normal or low
sodium intakes (Table 3). Changes in GFR, UNaV and 1Na after
HS at various levels of sodium intake are shown in Figure 3.
Discussion
HS-142-1, a polysaccharide fermentation product of Aureobasi-
dium sp, is a specific antagonist of natriuretic peptides, which
competes for binding sites at guanylyl cyclase-linked natriuretic
peptide receptors Lii, 12]. HS has been shown to block the actions
of the structurally related natriuretic peptides BNP, urodilatin
and C-type natriuretic peptide [13, 14]. While earlier studies have
shown that the diuretic and natriuretic responses to volume
expansion may be blocked by specific anti-ANP anti-serum [15], a
pharmacologic blocker of natriuretic peptide receptors provides a
more precise tool for assessing the contribution of all NP to the
functional adaptations to renal mass reduction. In protocol A we
established that acute administration of HS markedly blunted the
diuretic and natriuretic responses to acute saline loading in the
euvolemic MUnich-Wistar rat, confirming a previous report of
similar findings in Sprague-Dawley rats, restricted to assessment
of V and electrolyte excretion only [6]. Our data show that both
renal components of the natriuretic response, that is, increases in
filtered load and decreased tubule reabsorption of sodium, are
blocked by HS. That the diuretic and natriuretic responses to
acute saline loading are not completely abrogated in either study
is not altogether surprising, since several other factors, such as
reduced activity of renal sympathetic nerves, inhibition of vaso-
pressin release, decreased renin-angiotensin system activity, and
peritubular physical factors are also thought to contribute to the
natriuretic response to acute saline loading [16, 17]. The degree to
which FENa and natriuresis is blunted, however, is remarkable,
suggesting that natriuretic peptides are factors of prime impor-
tance in mediating the acute renal responses to saline loading in
anesthetized rats, at least over the time period observed in our
study. In previous studies, we found that, using the same dose of
HS (20 mg/kg) in normal euvolemic rats, GFR was reduced by
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In experimental models of chronic renal failure, a reduction in
functioning renal mass leads to retention of sodium and water
which contributes to the development of systemic and glomerular
capillary hypertension, adaptations which ultimately prove detri-
mental to the remnant kidney [1, 19]. One adaptive mechanism to
counteract this tendency to excessive fluid retention is a decrease
in sodium and water reabsorption by the renal tubules, as
reflected in higher FENa in the remnant kidney [1]. In protocol B,
the reductions in UNaV and FENa from elevated to near-normal
levels following blockade of the natriuretic receptor, strongly
suggest that natriuretic peptides contribute in large part to the
elevated FENa in sodium replete NPX rats, at both 3 and 14 days
after NPX. These observations are concordant with the data on
plasma ANP levels and the responses to anti-ANP antiserum in
NPX Münich-Wistar rats obtained under comparable experimen-
tal conditions in previously published studies from this laboratory
[2, 3]. These data showed that plasma ANP levels were elevated in
NPX rats on high sodium intake, but decreased in response to
dietary sodium restriction. As in our present study, the reductions
in UNaV and FENa observed in rats on low sodium diet following
anti-ANP antibody were of markedly lesser magnitude than in
those on high salt diet [2]. Taken together, these observations
provide strong evidence that natriuretic peptides are of critical
importance in mediating the adaptive decreases in tubule sodium
reabsorption that occur in the remnant kidney in response to renal
mass reduction under sodium-replete conditions. While the pre-
viously obtained radioimmunoassay data clearly implicate atrial
natriuretic peptide in contributing to these adaptive functional
responses, our current HS data leave open the possibility of a
contributory role for other structurally related natriuretic pep-
tides; identification of their relative contributions is the subject of
work in progress in this laboratory.
In addition to alterations in tubule sodium and volume reab-
sorption, the other adaptive mechanism which promotes renal
excretion of sodium and water is increased GFR per remnant
nephron and hence increased filtered load of sodium. Glomerular
hyperfiltration in NPX rats at 3 days is due largely to increased
glomerular capillary pressure, which is in turn determined by
preferential afferent arteriolar vasodilation and increased glomer-
ular blood flow [1]. The mechanism whereby exogenous ANP,
when administered in high doses, increases GFR is similar:
preglomerular vasodilation, small or negligible increments in
efferent arteriolar resistance, and elevation of the ultrafiltration
coefficient (ICe) [20]. Our present data concerning whole kidney
GFR and ERPF in NPX rats indicate that blockade of natriuretic
peptide receptors with HS reduced GFR in rats on high or normal
salt intake at 14 days, as well as at 3 days post-NPX. Interestingly,
the level to which GFR was reduced in high salt rats at 3 days is
close to the value that may be anticipated from 5/6 reduction in
total filtration capacity, assuming no adaptive increase in remnant
function takes place (approximately 0.35 ml/min). ERPF was also
reduced significantly in rats on high salt intake, but not on normal
salt intake. In contrast, both GFR and ERPF were unaffected by
HS in rats on low salt intake. At 14 days, the data clearly
demonstrate that natriuretic peptides contribute, to a large extent,
to the maintenance of both GFR and ERPF under sodium-replete
conditions. If anything, the renal hemodynamic responses to HS
are greater at 14 days than at 3 days: a 56% reduction in GFR
versus 36% at 3 days, and a 51% reduction in ERPF versus 17%
at 3 days. This interesting observation suggests that, with time, the
A 3 days after NPX 14 days after NPX
*
B
*
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! 0.0
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—0.4
0
4
J-4
U-
C
—6
—8
Fig. 3. Changes (A) in: (A) glomendar filtration rate (GFR), (B) sodium
excretion rate (UI'), and (C) fractional sodium excretion (FENa) following
HS in rats 3 or 14 days after 5/6 nephrectomy (NPX), at each level of sodium
intake. Symbols are: (fl) high sodium; () normal sodium; (0) low
sodium. Values represent mean sa. C 0.05 vs. changes in GFR,
UNaV and FENa after vehicle administration, respectively.
20% but was unchanged under hydropenic conditions [18], sug-
gesting that the renal hemodynamic responses to HS are deter-
mined by changes in volume status and therefore natriuretic
peptide activity. These studies also show that HS lacks non-
specific effects on GFR.
C
*
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Table 3. Mean arterial pressure (MAP), glomerular filtration rate (GFR), effective renal plasma flow rate (ERPF), urine flow rate (V), sodium
excretion rate (UNaV), fractional excretion of sodium (FENa) and hematocrit (Hct) in response to vehicle or HS in euvolemic rats 14 days after 5/6
nephrectomy on high, normal (Nor) and low sodium intakes
N
MAP
Pre
mm Hg
Post
GFR
Pre
mI/mm
Post
ERPF
Pre
mi/mm
Post
V
Pre
d/min
Post
UNaV
Pre
pEq/min
Post
FEN
Pre
a %
Post
He
Pre
t %
Post
HighVa 6
HighHSh 8
138
135
149
151C
0.62
0.52
0.61
022cd
2.29
1.79
2.21
083cd
32.7
29.0
35.6
4.6"
5.5
4.8
6.1
O.36
5.7
1.1
39
2
33"
Nor-V 6 146
12
140 0.56 0.50 1.87 1.47 26.3 24.4 2.9 2.6 3.8
1.3
3.7
1.3
41
2
Nor-HS 8 149 154 0.66 0.52 2.34 2.51 24.7 9.6 2.7 O.54" 3.2 07cd 39 37
Low-V 6 122 125 0.49 0.41 2.074 1.96 10.8 10.2 0.23 0.15 0.39 0.25 45
1
45
1
Low-HS 6 125 130 0.51 0.44c 2.18 2.16 6.1
1.0
4.5 0.15 0.05c 0.23 0.07c 42
1
41
1
Values are means SE.
a V, vehiclebHS, 20 mg/kg
P < 0.05 vs. pre value within each groupdP < 0.05 vs. vehicle group
maintenance of remnant kidney function becomes increasingly
dependent upon the activity of natriuretic peptides.
These findings are at variance with our earlier report showing
that while FENa was reduced by anti-ANP antiserum, GFR in high
salt NPX rats was unaffected [3]. This may be due to the relatively
low doses of ANP antiserum used, or alternatively, to differences
in accessibility of these agents to their target sites. While immu-
noglobulin may be well suited to binding and thus inactivating
circulating ANP, by virtue of its high molecular weight its access
to natriuretic peptides generated within the kidney itself may be
restricted. HS, on the other hand, a relatively low molecular
weight polysaccharide, may be expected to have greater tissue
penetrance, thus gaining access to natriuretic peptide receptors
within the renal parenchyma.
Interestingly, as reported previously [3, 21], basal levels of GFR
and ERPF between NPX rats on high or low salt diet are not
significantly different. This observation suggests that factors other
than natriuretic peptides serve to sustain glomerular hyperfiltra-
tion and hyperperfusion in this model during salt restricted
conditions. Possible candidates include angiotensin, prostaglan-
dins and nitric oxide. Tubule reabsorption of sodium, on the other
hand, appears to be more sensitive to the effects of HS, even
under the condition of salt restriction [18]. This is in keeping with
the overall tendency for the renal tubules to be more responsive to
small changes in natriuretic peptide activity than the determinants
of renal hemodynamics. In our previous studies neither GFR nor
FENa was reduced under hydropenic conditions. Thus, it is
possible that the reductions in FENa observed in the low salt
groups in this study reflect the effects of euvolemic preparation.
Alternatively, activity of locally produced natriuretic peptides,
such as urodilatin, may not be entirely suppressed under low
sodium conditions.
In experimental animals, sustained glomerular hypertension
has been shown to produce injuly to the constituent cells of the
glomerulus resulting in the histopathologic picture of focal and
segmental glomerular sclerosis and hyalinosis [1, 19]. Ultimately,
functioning nephrons are lost, thus reinforcing the stimulus to
compensatory hypertrophy and hyperfunction acting on remnant
nephrons. Since dietary sodium restriction in NPX rats has been
demonstrated to reduce glomerular injury [21], suppression of
natriuretic peptide activity in the kidney could also possibly limit
the development of structural injury in NPX rats. Since our
present data indicate an important role for natriuretic peptides in
maintaining elevations in GFR and FENa per nephron under
salt-replete conditions, chronic administration of HS to NPX rats
may serve to suppress the development of maladaptive glomerular
hemodynamic responses and thereby retard, or even abolish the
ultimate development of glomerulosclerosis. These chronic stud-
ies await synthesis of the suitably large quantities of HS needed to
perform them.
In summary, we confirm that HS inhibits the diuretic and
natriuretic responses to acute volume expansion in normal rats.
These effects of HS on renal excretory function may be largely
explained by inhibition of the known pharmacologic effects of
ANP or other natriuretic peptides on the renal glomerulus and
tubules. In NPX rats we now show that under sodium replete
conditions, GFR and FENa are markedly reduced following HS
administration, but not in rats on low salt intake. These data
suggest that natriuretic peptides mediate the compensatory in-
creases in GFR, ERPF and tubule sodium excretion in the
remnant kidney under sodium-replete conditions, and that dietary
sodium restriction, which prevents volume expansion and there-
fore the increase in ANP secretion, prevents or ameliorates these
effects.
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